US Stock MarketDetailed Quotes

URGN UroGen Pharma Ltd

Watchlist
  • 12.900
  • +0.150+1.18%
Close Sep 27 16:00 ET
  • 12.900
  • 0.0000.00%
Post 16:02 ET
543.27MMarket Cap-4174P/E (TTM)

UroGen Pharma Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
3.35%21.85M
9.24%18.78M
28.52%82.71M
30.06%23.53M
29.54%20.85M
27.31%21.14M
26.75%17.19M
33.96%64.36M
11.86%18.09M
41.81%16.1M
Operating revenue
3.35%21.85M
9.24%18.78M
28.52%82.71M
30.06%23.53M
29.54%20.85M
27.31%21.14M
26.75%17.19M
33.96%64.36M
11.86%18.09M
41.81%16.1M
Cost of revenue
-8.76%2.23M
-23.71%1.73M
22.30%9.36M
1.02%2.29M
17.18%2.37M
32.34%2.44M
48.52%2.27M
48.42%7.65M
42.42%2.26M
62.38%2.02M
Gross profit
4.94%19.62M
14.24%17.05M
29.36%73.35M
34.21%21.24M
31.31%18.49M
26.68%18.7M
23.99%14.93M
32.22%56.7M
8.53%15.83M
39.28%14.08M
Operating expense
33.39%45.46M
15.74%42.79M
2.32%138.89M
-0.71%35.85M
-0.56%31.99M
1.81%34.08M
8.75%36.97M
0.42%135.74M
4.67%36.11M
-4.12%32.16M
Selling and administrative expenses
33.62%30.06M
11.54%27.3M
12.60%93.27M
13.48%24.55M
14.07%21.76M
7.97%22.49M
14.90%24.47M
-5.37%82.84M
1.01%21.63M
-11.81%19.07M
Research and development costs
32.96%15.4M
23.97%15.49M
-13.78%45.61M
-21.93%11.3M
-21.87%10.23M
-8.35%11.58M
-1.56%12.5M
11.05%52.91M
10.66%14.48M
9.81%13.09M
Operating profit
-67.98%-25.84M
-16.76%-25.74M
17.09%-65.54M
27.97%-14.61M
25.36%-13.5M
17.81%-15.38M
-0.40%-22.05M
14.36%-79.04M
-1.84%-20.28M
22.84%-18.09M
Net non-operating interest income expense
47.71%-1.74M
77.68%-649K
-60.99%-12.07M
-3.85%-2.86M
-32.27%-2.98M
-57.56%-3.33M
-938.57%-2.91M
-3,637.74%-7.5M
-1,970.68%-2.75M
-4,052.63%-2.25M
Non-operating interest income
295.86%1.72M
178.76%1.8M
181.56%2.64M
54.80%726K
89.34%835K
239.84%435K
32,150.00%645K
156.99%938K
2,245.00%469K
673.68%441K
Non-operating interest expense
-7.98%3.46M
-31.13%2.45M
74.39%14.72M
11.26%3.59M
41.61%3.82M
67.98%3.76M
1,159.93%3.55M
--8.44M
--3.22M
--2.69M
Other net income (expense)
-7.69%-5.79M
-11.53%-5.84M
3.60%-20.71M
8.77%-4.69M
-13.09%-5.41M
7.87%-5.37M
10.14%-5.24M
-24.27%-21.49M
29.21%-5.14M
29.96%-4.78M
Gain on sale of security
-8.03%-5.77M
-8.35%-5.66M
0.03%-21.55M
-8.34%-5.51M
-13.70%-5.48M
8.38%-5.34M
10.33%-5.22M
-24.68%-21.56M
30.80%-5.08M
29.42%-4.82M
Other non- operating income (expenses)
53.33%-14K
-1,120.00%-183K
1,063.89%838K
1,388.89%812K
91.89%71K
---30K
-275.00%-15K
--72K
---63K
--37K
Income before tax
-38.55%-33.37M
-6.76%-32.23M
8.98%-98.32M
21.36%-22.16M
12.87%-21.89M
9.67%-24.08M
-7.57%-30.19M
1.23%-108.03M
-3.17%-28.18M
16.84%-25.12M
Income tax
-29.63%38K
157.14%54K
123.36%3.92M
459.36%3.85M
-101.27%-9K
68.75%54K
-93.54%21K
21.12%1.76M
-39.40%689K
709K
Net income
-38.39%-33.4M
-6.86%-32.29M
6.87%-102.24M
9.88%-26.02M
15.30%-21.88M
9.57%-24.14M
-6.41%-30.21M
0.94%-109.78M
-1.47%-28.87M
14.50%-25.83M
Net income continuous Operations
-38.39%-33.4M
-6.86%-32.29M
6.87%-102.24M
9.88%-26.02M
15.30%-21.88M
9.57%-24.14M
-6.41%-30.21M
0.94%-109.78M
-1.47%-28.87M
14.50%-25.83M
Minority interest income
Net income attributable to the parent company
-38.39%-33.4M
-6.86%-32.29M
6.87%-102.24M
9.88%-26.02M
15.30%-21.88M
9.57%-24.14M
-6.41%-30.21M
0.94%-109.78M
-1.47%-28.87M
14.50%-25.83M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-38.39%-33.4M
-6.86%-32.29M
6.87%-102.24M
9.88%-26.02M
15.30%-21.88M
9.57%-24.14M
-6.41%-30.21M
0.94%-109.78M
-1.47%-28.87M
14.50%-25.83M
Basic earnings per share
11.65%-0.91
25.38%-0.97
26.20%-3.55
45.90%-0.66
39.82%-0.68
12.71%-1.03
-4.00%-1.3
3.02%-4.81
3.94%-1.22
16.30%-1.13
Diluted earnings per share
11.65%-0.91
25.38%-0.97
26.20%-3.55
45.90%-0.66
39.82%-0.68
12.71%-1.03
-4.00%-1.3
3.02%-4.81
3.94%-1.22
16.30%-1.13
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 3.35%21.85M9.24%18.78M28.52%82.71M30.06%23.53M29.54%20.85M27.31%21.14M26.75%17.19M33.96%64.36M11.86%18.09M41.81%16.1M
Operating revenue 3.35%21.85M9.24%18.78M28.52%82.71M30.06%23.53M29.54%20.85M27.31%21.14M26.75%17.19M33.96%64.36M11.86%18.09M41.81%16.1M
Cost of revenue -8.76%2.23M-23.71%1.73M22.30%9.36M1.02%2.29M17.18%2.37M32.34%2.44M48.52%2.27M48.42%7.65M42.42%2.26M62.38%2.02M
Gross profit 4.94%19.62M14.24%17.05M29.36%73.35M34.21%21.24M31.31%18.49M26.68%18.7M23.99%14.93M32.22%56.7M8.53%15.83M39.28%14.08M
Operating expense 33.39%45.46M15.74%42.79M2.32%138.89M-0.71%35.85M-0.56%31.99M1.81%34.08M8.75%36.97M0.42%135.74M4.67%36.11M-4.12%32.16M
Selling and administrative expenses 33.62%30.06M11.54%27.3M12.60%93.27M13.48%24.55M14.07%21.76M7.97%22.49M14.90%24.47M-5.37%82.84M1.01%21.63M-11.81%19.07M
Research and development costs 32.96%15.4M23.97%15.49M-13.78%45.61M-21.93%11.3M-21.87%10.23M-8.35%11.58M-1.56%12.5M11.05%52.91M10.66%14.48M9.81%13.09M
Operating profit -67.98%-25.84M-16.76%-25.74M17.09%-65.54M27.97%-14.61M25.36%-13.5M17.81%-15.38M-0.40%-22.05M14.36%-79.04M-1.84%-20.28M22.84%-18.09M
Net non-operating interest income expense 47.71%-1.74M77.68%-649K-60.99%-12.07M-3.85%-2.86M-32.27%-2.98M-57.56%-3.33M-938.57%-2.91M-3,637.74%-7.5M-1,970.68%-2.75M-4,052.63%-2.25M
Non-operating interest income 295.86%1.72M178.76%1.8M181.56%2.64M54.80%726K89.34%835K239.84%435K32,150.00%645K156.99%938K2,245.00%469K673.68%441K
Non-operating interest expense -7.98%3.46M-31.13%2.45M74.39%14.72M11.26%3.59M41.61%3.82M67.98%3.76M1,159.93%3.55M--8.44M--3.22M--2.69M
Other net income (expense) -7.69%-5.79M-11.53%-5.84M3.60%-20.71M8.77%-4.69M-13.09%-5.41M7.87%-5.37M10.14%-5.24M-24.27%-21.49M29.21%-5.14M29.96%-4.78M
Gain on sale of security -8.03%-5.77M-8.35%-5.66M0.03%-21.55M-8.34%-5.51M-13.70%-5.48M8.38%-5.34M10.33%-5.22M-24.68%-21.56M30.80%-5.08M29.42%-4.82M
Other non- operating income (expenses) 53.33%-14K-1,120.00%-183K1,063.89%838K1,388.89%812K91.89%71K---30K-275.00%-15K--72K---63K--37K
Income before tax -38.55%-33.37M-6.76%-32.23M8.98%-98.32M21.36%-22.16M12.87%-21.89M9.67%-24.08M-7.57%-30.19M1.23%-108.03M-3.17%-28.18M16.84%-25.12M
Income tax -29.63%38K157.14%54K123.36%3.92M459.36%3.85M-101.27%-9K68.75%54K-93.54%21K21.12%1.76M-39.40%689K709K
Net income -38.39%-33.4M-6.86%-32.29M6.87%-102.24M9.88%-26.02M15.30%-21.88M9.57%-24.14M-6.41%-30.21M0.94%-109.78M-1.47%-28.87M14.50%-25.83M
Net income continuous Operations -38.39%-33.4M-6.86%-32.29M6.87%-102.24M9.88%-26.02M15.30%-21.88M9.57%-24.14M-6.41%-30.21M0.94%-109.78M-1.47%-28.87M14.50%-25.83M
Minority interest income
Net income attributable to the parent company -38.39%-33.4M-6.86%-32.29M6.87%-102.24M9.88%-26.02M15.30%-21.88M9.57%-24.14M-6.41%-30.21M0.94%-109.78M-1.47%-28.87M14.50%-25.83M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -38.39%-33.4M-6.86%-32.29M6.87%-102.24M9.88%-26.02M15.30%-21.88M9.57%-24.14M-6.41%-30.21M0.94%-109.78M-1.47%-28.87M14.50%-25.83M
Basic earnings per share 11.65%-0.9125.38%-0.9726.20%-3.5545.90%-0.6639.82%-0.6812.71%-1.03-4.00%-1.33.02%-4.813.94%-1.2216.30%-1.13
Diluted earnings per share 11.65%-0.9125.38%-0.9726.20%-3.5545.90%-0.6639.82%-0.6812.71%-1.03-4.00%-1.33.02%-4.813.94%-1.2216.30%-1.13
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data